|
RPRD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.890200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.973400E-01 |
| Normal-vs-Stage2 |
7.836000E-01 |
| Normal-vs-Stage3 |
1.373410E-01 |
| Normal-vs-Stage4 |
6.847800E-01 |
| Stage1-vs-Stage2 |
5.951200E-01 |
| Stage1-vs-Stage3 |
9.230000E-02 |
| Stage1-vs-Stage4 |
8.225400E-01 |
| Stage2-vs-Stage3 |
1.584800E-01 |
| Stage2-vs-Stage4 |
5.553400E-01 |
| Stage3-vs-Stage4 |
3.341800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.127000E-01 |
| Normal-vs-AfricanAmerican |
1.313350E-01 |
| Normal-vs-Asian |
7.195600E-01 |
| Caucasian-vs-AfricanAmerican |
2.277900E-02 |
| Caucasian-vs-Asian |
1.731790E-01 |
| AfricanAmerican-vs-Asian |
3.054400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.328200E-01 |
| Normal-vs-Female |
6.182200E-01 |
| Male-vs-Female |
8.392400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.282200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.449000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.073800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.998000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.933600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.322600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.182000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.980600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.708200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.200600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.900300E-02 |
| Classical-VS-Follicular |
4.315200E-01 |
| Classical-VS-Other |
3.315400E-01 |
| Classical-VS-Normal |
8.622600E-01 |
| Tall-VS-Follicular |
9.475200E-03 |
| Tall-VS-Other |
8.658400E-01 |
| Tall-VS-Normal |
2.736400E-02 |
| Follicular-VS-Other |
3.245800E-01 |
| Follicular-VS-Normal |
6.190400E-01 |
| Other-VS-Normal |
2.622400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.078600E-01 |
| Normal-vs-N1 |
2.347200E-01 |
| N0-vs-N1 |
2.642800E-01 |
|
|
